Have there been any Lipovive recalls by the FDA in 2024 or 2025?

Checked on August 16, 2025
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

This fact-check may be outdated. Consider refreshing it to get the most current information.

Was this fact-check helpful?

1. Summary of the results

Based on the comprehensive analysis of multiple sources, there is no evidence of any FDA recalls of Lipovive in 2024 or 2025. The FDA's official recall databases and weight loss product notifications do not list Lipovive among recalled products [1] [2] [3].

The sources consistently show that:

  • FDA recall lists contain various food and drug products due to contamination, undeclared allergens, or safety issues, but Lipovive is not among them [2]
  • FDA weight loss product notifications focus on products with hidden drug ingredients, but Lipovive is not mentioned [1]
  • Lipovive continues to be actively marketed as a weight loss supplement with customer testimonials and refund policies [4] [3]

2. Missing context/alternative viewpoints

The original question lacks important regulatory context that emerges from the analyses:

  • The FDA has expressed concerns about unapproved GLP-1 drugs used for weight loss, warning specifically about counterfeit and illegally marketed versions of these drugs [5]. This is significant because Lipovive markets itself as supporting GLP-1 and GIP hormones [3].
  • Lipovive's marketing emphasizes "GLP-1 hormone science" and positions itself within weight loss trends for 2025 [4] [3], which places it in a category that the FDA is actively monitoring for compliance issues.
  • The supplement industry benefits financially from consumers believing their products are safe and effective without FDA oversight, as dietary supplements face less stringent regulation than prescription drugs.

3. Potential misinformation/bias in the original statement

The original question itself does not contain misinformation, as it is a straightforward factual inquiry. However, the context reveals potential areas of concern:

  • Marketing materials for Lipovive emphasize scientific credibility through references to "GLP-1 hormone science" and "real science" [4], which could mislead consumers into believing the product has FDA approval or clinical validation equivalent to prescription medications.
  • The absence of recalls does not indicate FDA approval or safety verification, as dietary supplements like Lipovive operate under different regulatory frameworks than prescription drugs, a distinction that may not be clear to consumers seeking recall information.
Want to dive deeper?
What are the common side effects of Lipovive reported to the FDA in 2024?
How many Lipovive products have been recalled by the FDA since 2020?
What is the current FDA stance on Lipovive's effectiveness for weight loss in 2025?
Can consumers report adverse reactions to Lipovive directly to the FDA?
Are there any class-action lawsuits against Lipovive manufacturers in 2024 or 2025?